Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of “Hold” from Brokerages

Masimo Corporation (NASDAQ:MASI) has received a consensus rating of “Hold” from the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $181.1667.

Several equities research analysts have recently issued reports on MASI shares. Wells Fargo & Company cut Masimo from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $190.00 to $180.00 in a report on Wednesday, February 18th. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 price objective on shares of Masimo in a report on Tuesday, February 17th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Monday, December 1st.

Institutional Trading of Masimo

Institutional investors have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the period. Assetmark Inc. grew its position in Masimo by 5.0% in the second quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider’s stock valued at $259,000 after acquiring an additional 73 shares in the last quarter. Clearstead Advisors LLC raised its stake in shares of Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73 shares during the period. Hantz Financial Services Inc. lifted its position in shares of Masimo by 12.9% during the fourth quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 75 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Masimo by 5.3% in the second quarter. ProShare Advisors LLC now owns 1,995 shares of the medical equipment provider’s stock valued at $336,000 after purchasing an additional 101 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Trading Up 0.1%

Shares of Masimo stock opened at $175.35 on Monday. The company has a 50-day moving average of $143.09 and a two-hundred day moving average of $143.94. Masimo has a 12-month low of $125.94 and a 12-month high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. The stock has a market cap of $9.42 billion, a PE ratio of -16.64, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.